121 related articles for article (PubMed ID: 2945790)
1. Evidence for HTLV-III/LAV expression by primary cultures of T8 cells.
Fouchard M; Reveil B; Mbayo K; Lurhuma A; Sarin PS; Gallo RC; Zagury D
Int J Cancer; 1986 Nov; 38(5):657-9. PubMed ID: 2945790
[TBL] [Abstract][Full Text] [Related]
2. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis of the acquired immunodeficiency syndrome.
Bowen DL; Lane HC; Fauci AS
Ann Intern Med; 1985 Nov; 103(5):704-9. PubMed ID: 2996403
[TBL] [Abstract][Full Text] [Related]
4. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK
Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 2 production in HTLV-III/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production.
Antonen J; Krohn K
Clin Exp Immunol; 1986 Sep; 65(3):489-96. PubMed ID: 2946497
[TBL] [Abstract][Full Text] [Related]
6. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
[TBL] [Abstract][Full Text] [Related]
7. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
[TBL] [Abstract][Full Text] [Related]
8. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men.
Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH
Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
Tschachler E; Groh V; Popovic M; Mann DL; Konrad K; Safai B; Eron L; diMarzo Veronese F; Wolff K; Stingl G
J Invest Dermatol; 1987 Feb; 88(2):233-7. PubMed ID: 3100656
[TBL] [Abstract][Full Text] [Related]
10. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
11. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
12. Detection of HTLV-III/LAV antigens in peripheral blood lymphocytes from patients with AIDS.
Pekovic DD; Chausseau JP; Lapointe N; Michaud J; Garzon S; Strykowski H; Tsoukas C; Gilmore N; Goldman H; Gornitsky M
Arch Virol; 1986; 91(1-2):11-9. PubMed ID: 3092784
[TBL] [Abstract][Full Text] [Related]
13. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
[TBL] [Abstract][Full Text] [Related]
14. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.
Klatzmann D; Barré-Sinoussi F; Nugeyre MT; Danquet C; Vilmer E; Griscelli C; Brun-Veziret F; Rouzioux C; Gluckman JC; Chermann JC
Science; 1984 Jul; 225(4657):59-63. PubMed ID: 6328660
[TBL] [Abstract][Full Text] [Related]
15. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
Dalgleish AG; Beverley PC; Clapham PR; Crawford DH; Greaves MF; Weiss RA
Nature; 1984 Dec 20-1985 Jan 2; 312(5996):763-7. PubMed ID: 6096719
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
17. Defect in B cell function in HTLV III/LAV positive hemophilia patients.
Sjamsoedin-Visser EJ; Heijnen CJ; Zegers BJ; Stoop JW
Blood; 1987 May; 69(5):1388-93. PubMed ID: 2952185
[TBL] [Abstract][Full Text] [Related]
18. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.
Zagury D; Bernard J; Leonard R; Cheynier R; Feldman M; Sarin PS; Gallo RC
Science; 1986 Feb; 231(4740):850-3. PubMed ID: 2418502
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
20. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
